Abstract
The human c-abl oncogene maps within the region (q34-qter) of chromosome 9 which is translocated to chromosome 22, the Philadelphia (Ph′) chromosome, in chronic myelocytic leukaemia (CML). The position of the Ph′ chromosomal break point is shown to be variable and, in one CML patient, has been localized immediately 5′ of, or within, the c-abl oncogene. A DNA restriction fragment corresponding to this site has been molecularly cloned and shown to represent a chimaeric fragment of DNA from chromosomes 9 and 22.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis
Cancer Gene Therapy Open Access 23 August 2022
-
Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution
Egyptian Journal of Medical Human Genetics Open Access 06 March 2022
-
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Nature Communications Open Access 12 January 2022
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Pulciani, S. et al. Nature 300, 539–542 (1982).
Der, C. J., Krontiris, T. G. & Cooper, G. M. Proc. natn. Acad. Sci. U.S.A. 79, 3637–3640 (1982).
Tabin, C. J. et al. Nature 300, 143–149 (1982).
Taparowsky, E. et al. Nature 300, 762–765 (1982).
Shimizu, K. et al. Proc. natn. Acad. Sci. U.S.A. 80, 2112–2116 (1983).
Collins, S. & Groudine, M. Nature 298, 679–681 (1982).
Dalla-Favera, R., Wong-Staal, F. & Gallo, R. Nature 299, 61–63 (1982).
Alitalo, K., Schwab, M., Lin, C., Varmus, H. E. & Bishop, J. M. Proc. natn. Acad. Sci. U.S.A. 80, 1707–1711 (1983).
de Klein, A. et al. Nature 300, 765–767 (1982).
Taub, R. et al. Proc. natn. Acad. Sci. U.S.A. 79, 7837–7841 (1982).
Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. M. & Cary, S. Proc. natn. Acad Sci. U.S.A. 80, 1982–1986 (1983).
Dalla-Favera, R. et al. Science 219, 963–967 (1983).
Sheer, D. et al. Proc. natn. Acad. Sci. U.S.A. 80, 5007–5011 (1983).
Goff, S. P., Gilboa, E., Witte, O. N. & Baltimore, D. Cell 22, 777–785 (1980).
Rosenberg, N., Blatimore, D. & Scher, C. Proc. natn. Acad. Sci. U.S.A. 72, 1932–1936 (1975).
Abelson, H. T. & Rabstein, L. S. Cancer Res. 30, 2213–2222 (1970).
Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. 2, 57–69 (1983).
Groffen, J., Heisterkamp, N., Reynolds, F. Jr. & Stephenson, J. R. Nature 304, 167–169 (1983).
Heisterkamp, N. et al. Nature 299, 747–750 (1982).
Rowley, J. D. Nature 243, 290–293 (1973).
Lozzio, C. B. & Lozzio, B. B. Blood 45, 321–334 (1975).
Groffen, J., Heisterkamp, N., Grosveld, G., van de Ven, W. & Stephenson, J. R. Science 216, 1136–1138 (1982).
Weinstock, G. M. et al. Proc. natn. Acad. Sci. U.S.A. 80, 4432–4436 (1983).
Klein, E. et al. Int. J. Cancer 18, 421–431 (1976).
Hieter, P. A., Hollis, G. F., Korsmeyer, S. J., Waldmann, T. A. & Leder, P. Nature 294, 536–540 (1981).
Groffen, J. et al. J. exp. Med. 158, 9–15 (1983).
Stanton, L. W., Watt, R. & Marcu, K. B. Nature 303, 401–406 (1983).
Groffen, J. et al. Nucleic Acids Res. (in the press).
Bartram, C. R. et al. Nature 306, 277–280 (1983).
Jeffreys, A. J. & Flavell, R. A. Cell 12, 429–439 (1977).
Southern, E. M. J. molec. Biol. 98, 503–517 (1975).
Bernards, R. & Flavell, R. A. Nucleic Acids Res. 8, 1421–1533 (1980).
Groffen, J., Heisterkamp, N., Blennerhassett, G. & Stephenson, J. R. Virology 126, 213–227 (1983).
Swan, D. C. et al. Proc. natn. Acad. Sci. U.S.A. 79, 4691–4696 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heisterkamp, N., Stephenson, J., Groffen, J. et al. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306, 239–242 (1983). https://doi.org/10.1038/306239a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/306239a0
This article is cited by
-
Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis
Cancer Gene Therapy (2023)
-
Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution
Egyptian Journal of Medical Human Genetics (2022)
-
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
Nature Communications (2022)
-
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Stem Cell Research & Therapy (2021)
-
Influence of genetic polymorphisms in glutathione-S-transferases gene in response to imatinib among Brazilian patients with chronic myeloid leukemia
Molecular Biology Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.